{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:40Z","timestamp":1791357280259,"version":"4.3.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jad.2016.06.016","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T02:50:00Z","timestamp":1465267800000},"page":"364-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review"],"prefix":"10.1016","volume":"203","author":[{"given":"Seline","family":"van den Ameele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"van Diermen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violette","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Sabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2016.06.016_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.exger.2013.08.006","article-title":"Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to lithium chloride","volume":"48","author":"Agrawal","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jad.2016.06.016_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur. Arch. psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2016.06.016_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2194-7511-1-5","article-title":"Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data","volume":"1","author":"Bauer","year":"2013","journal-title":"Int. J. bipolar Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40345-015-0037-x","article-title":"Inflammatory monocyte gene expression: trait or state marker in bipolar disorder?","volume":"3","author":"Becking","year":"2015","journal-title":"Int. J. bipolar Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jad.2016.06.016_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","author":"Boufidou","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-3223(02)01452-X","article-title":"High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder","volume":"53","author":"Breunis","year":"2003","journal-title":"Biol. psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib8","first-page":"301","article-title":"The effects of lithium therapy on leukocytes: a 1-year follow-up study","volume":"85","author":"Carmen","year":"1993","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.jad.2016.06.016_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-244X-12-158","article-title":"Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms","volume":"12","author":"Cetin","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2016.06.016_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00406-007-0797-0","article-title":"Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder","volume":"258","author":"Cunha","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2016.06.016_bib12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"Dickerson","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis","volume":"54","author":"Diez-Ruiz","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jad.2016.06.016_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2016.06.016_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2016.06.016_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2015.08.036","article-title":"Peripheral inflammation during abnormal mood states in bipolar I disorder","volume":"187","author":"Fiedorowicz","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2016.06.016_bib18","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","author":"Goldstein","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2012.04.044","article-title":"Evidence for an association between tumor necrosis factor-alpha levels and lithium response","volume":"143","author":"Guloksuz","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","author":"Guloksuz","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3956(99)00021-7","article-title":"Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis","volume":"33","author":"Haack","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bdi.12142","article-title":"Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder \u2013 towards a better understanding of psychoimmunological interactions","volume":"16","author":"Haarman","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib23","first-page":"5","article-title":"Lithium salts in AIDS and AIDS-related dementia","volume":"36","author":"Harvey","year":"2002","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2016.06.016_bib24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jpsychires.2013.07.026","article-title":"Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro","volume":"47","author":"Himmerich","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib25","doi-asserted-by":"crossref","first-page":"806162","DOI":"10.1155\/2014\/806162","article-title":"Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro","volume":"2014","author":"Himmerich","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jad.2016.06.016_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","article-title":"Impact of antipsychotics on cytokine production in-vitro","volume":"45","author":"Himmerich","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-0327(97)00180-8","article-title":"Positive and negative acute phase proteins in affective subtypes","volume":"49","author":"Hornig","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2016.06.016_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4000494","article-title":"Anti-bipolar therapy: mechanism of action of lithium","volume":"4","author":"Jope","year":"1999","journal-title":"Mol. psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2004.08.005","article-title":"T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients","volume":"129","author":"Kim","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2016.06.016_bib32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs","volume":"7","author":"Kim","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jlb.46.5.484","article-title":"Lithium chloride stimulates human monocytes to secrete tumor necrosis factor\/cachectin","volume":"46","author":"Kleinerman","year":"1989","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jad.2016.06.016_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","article-title":"An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment","volume":"9","author":"Knijff","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Cytokines and the brain: implications for clinical psychiatry","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","article-title":"The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial","volume":"34","author":"Lee","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.06.016_bib37","first-page":"879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. The journals of gerontology","volume":"63","author":"Leng","year":"2008","journal-title":"Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jad.2016.06.016_bib38","first-page":"949248","article-title":"Functional outcome in bipolar disorder: the big picture","volume":"2012","author":"Levy","year":"2012","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.jad.2016.06.016_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2014.12.033","article-title":"IL-23 and TGF-beta1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode","volume":"174","author":"Li","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jad.2016.06.016_bib41","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0306-9877(81)90043-8","article-title":"Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate","volume":"7","author":"Lieb","year":"1981","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jad.2016.06.016_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2004.01.006","article-title":"Immunologic variables in acute mania of bipolar disorder","volume":"150","author":"Liu","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jad.2016.06.016_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2016.06.016_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0306-4530(94)00066-J","article-title":"The monocyte-T-lymphocyte hypothesis of major depression","volume":"20","author":"Maes","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2016.06.016_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002130050965","article-title":"In vitro immunoregulatory effects of lithium in healthy volunteers","volume":"143","author":"Maes","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2016.06.016_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fpsyt.2014.00098","article-title":"Integrated neurobiology of bipolar disorder","volume":"5","author":"Maletic","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib50","first-page":"129","article-title":"Cytokines, epilepsy and epileptic drugs\u2013is there a mutual influence?","volume":"59","author":"Mlodzikowska-Albrecht","year":"2007","journal-title":"Pharmacol. Rep.: PR"},{"key":"10.1016\/j.jad.2016.06.016_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jad.2016.06.016_bib53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.58.9.585","article-title":"Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines","volume":"58","author":"Moots","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jad.2016.06.016_bib54","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib55","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbi.2009.04.005","article-title":"To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers","volume":"23","author":"O\u2019Connor","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2016.06.016_bib56","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dominguez","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.65.4.395","article-title":"A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes","volume":"65","author":"Padmos","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00702-014-1328-6","article-title":"Impact of lithium alone and in combination with antidepressants on cytokine production in vitro","volume":"122","author":"Petersein","year":"2015","journal-title":"J. neural Transm."},{"key":"10.1016\/j.jad.2016.06.016_bib59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MOH.0b013e32834da93b","article-title":"Lithium in the treatment of neutropenia","volume":"19","author":"Petrini","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jad.2016.06.016_bib60","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2016.06.016_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0327(94)90012-4","article-title":"Immune parameters in euthymic bipolar patients and normal volunteers","volume":"32","author":"Rapaport","year":"1994","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-3956(99)00007-2","article-title":"Immune parameters in rapid cycling bipolar patients before and after lithium treatment","volume":"33","author":"Rapaport","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-3223(01)01144-1","article-title":"The effects of lithium on ex vivo cytokine production","volume":"50","author":"Rapaport","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000339949","article-title":"Selected cytokine profiles during remission in bipolar patients","volume":"66","author":"Remlinger-Molenda","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2016.06.016_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/pdia.2014.40954","article-title":"Interleukin-17 in human inflammatory diseases","volume":"31","author":"Shabgah","year":"2014","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.jad.2016.06.016_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02121762","article-title":"The effect of lithium chloride on the replication of herpes simplex virus","volume":"168","author":"Skinner","year":"1980","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jad.2016.06.016_bib68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000119332","article-title":"Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression","volume":"35","author":"Sluzewska","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2016.06.016_bib69","doi-asserted-by":"crossref","DOI":"10.3310\/hta11390","article-title":"A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder","volume":"11","author":"Soares-Weiser","year":"2007","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jad.2016.06.016_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/YCO.0b013e32835aa4b4","article-title":"Is bipolar disorder an inflammatory condition? The relevance of microglial activation","volume":"26","author":"Stertz","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.03.020","article-title":"Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation","volume":"707","author":"Suda","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2016.06.016_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.06.016_bib73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hup.2450","article-title":"Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment","volume":"30","author":"Teixeira","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.06.016_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3956(02)00103-6","article-title":"Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission","volume":"37","author":"Tsai","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","author":"Tsai","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib77","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.psychres.2015.05.078","article-title":"Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment","volume":"228","author":"Uyanik","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2016.06.016_bib78","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/hup.2381","article-title":"Microarray analysis of global gene expression in leukocytes following lithium treatment","volume":"29","author":"Watanabe","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2016.06.016_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2014.05.024","article-title":"Interleukin-6 and its receptors: a highly regulated and dynamic system","author":"Wolf","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.jad.2016.06.016_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","article-title":"Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells","volume":"34","author":"Xia","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jad.2016.06.016_bib81","first-page":"367","article-title":"Haloperidol Suppresses NF-kappaB to Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Response in RAW 264 Cells. Medical science monitor","volume":"22","author":"Yamamoto","year":"2016","journal-title":"Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jad.2016.06.016_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMA)T) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.06.016_bib83","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MCO.0b013e32833cf3bc","article-title":"Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research","volume":"13","author":"Zhou","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S016503271630307X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S016503271630307X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T05:45:08Z","timestamp":1568007908000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271630307X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":83,"alternative-id":["S016503271630307X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2016.06.016","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.jad.2016.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}